Showing results (261-270 of 297) with videos related to

Sort By:
Pageof 30
Molecular Cancer Research : MCR|August 9, 2014
TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genesLiang Liu, Weiying Zhou, Chun-Ting Cheng, et al.
British Journal of Haematology|July 16, 2023
Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphomaFenghua Gao, Hengqi Liu, Xiangrui Meng, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 10, 2018
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCLLinyu Li, Xuhan Zhang, Tingting Zhang, et al.
Cancer Research|April 5, 2012
CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cellsAkihiro Tsuyada, Amy Chow, Jun Wu, et al.
Frontiers in Oncology|April 18, 2022
Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002)Xiaobin Shang, Wencheng Zhang, Gang Zhao, et al.
Nature Cell Biology|April 18, 2018
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cellsWei Yan, Xiwei Wu, Weiying Zhou, et al.
Scientific Reports|February 7, 2026
Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinomaShuzhan Li, Jing Qin, Qian Sun, et al.
Frontiers in Immunology|December 23, 2021
The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer-A Phase II StudyWenqun Xing, Lingdi Zhao, Yan Zheng, et al.
JCI Insight|April 14, 2017
Efficacy of ALK5 inhibition in myelofibrosisLanzhu Yue, Matthias Bartenstein, Wanke Zhao, et al.
The Oncologist|April 24, 2021
Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell CarcinomaWencheng Zhang, Cihui Yan, Xuan Gao, et al.
Pageof 30